Tumor-associated macrophages (TAMs), including both M1 (CD68+) and M2-type (CD163+), were shown to be the most numerous immune cells infiltrating thyroid carcinoma (Liu et al., 2022). This evidence concerns the gene CD163 and thyroid gland carcinoma.